AMN Healthcare Services (AMN) Competitors

AMN Healthcare Services logo
$35.76 +1.41 (+4.10%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$35.68 -0.08 (-0.22%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AMN vs. EYE, MEDP, VEEV, WST, and LFST

Should you buy AMN Healthcare Services stock or one of its competitors? AMN Healthcare Services's main competitors and comparable companies include National Vision (EYE), Medpace (MEDP), Veeva Systems (VEEV), West Pharmaceutical Services (WST), and LifeStance Health Group (LFST). Companies are selected based on similarities in market, industry, and size.

How does AMN Healthcare Services compare to National Vision?

AMN Healthcare Services (NYSE:AMN) and National Vision (NASDAQ:EYE) are related small-cap companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, media sentiment, dividends, valuation and earnings.

National Vision has lower revenue, but higher earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AMN Healthcare Services$2.73B0.51-$95.70M$2.7513.00
National Vision$1.99B0.66$29.60M$0.8120.64

National Vision has a net margin of 3.21% compared to AMN Healthcare Services' net margin of 3.10%. AMN Healthcare Services' return on equity of 23.42% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
AMN Healthcare Services3.10% 23.42% 7.19%
National Vision 3.21%8.07%3.60%

AMN Healthcare Services presently has a consensus target price of $39.17, indicating a potential upside of 9.53%. National Vision has a consensus target price of $29.27, indicating a potential upside of 75.13%. Given National Vision's stronger consensus rating and higher probable upside, analysts plainly believe National Vision is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AMN Healthcare Services
1 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.33
National Vision
0 Sell rating(s)
4 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.64

AMN Healthcare Services has a beta of 0.42, meaning that its share price is 58% less volatile than the broader market. Comparatively, National Vision has a beta of 0.96, meaning that its share price is 4% less volatile than the broader market.

In the previous week, AMN Healthcare Services and AMN Healthcare Services both had 4 articles in the media. AMN Healthcare Services' average media sentiment score of 0.58 beat National Vision's score of 0.31 indicating that AMN Healthcare Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AMN Healthcare Services
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
National Vision
0 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

99.2% of AMN Healthcare Services shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by company insiders. Comparatively, 2.4% of National Vision shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

National Vision beats AMN Healthcare Services on 9 of the 15 factors compared between the two stocks.

How does AMN Healthcare Services compare to Medpace?

Medpace (NASDAQ:MEDP) and AMN Healthcare Services (NYSE:AMN) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

Medpace has higher earnings, but lower revenue than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medpace$2.53B6.74$451.12M$18.0433.78
AMN Healthcare Services$2.73B0.51-$95.70M$2.7513.00

In the previous week, Medpace and Medpace both had 4 articles in the media. Medpace's average media sentiment score of 0.70 beat AMN Healthcare Services' score of 0.58 indicating that Medpace is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Medpace
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AMN Healthcare Services
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Medpace has a beta of 1.12, meaning that its stock price is 12% more volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.42, meaning that its stock price is 58% less volatile than the broader market.

Medpace currently has a consensus price target of $649.27, suggesting a potential upside of 6.55%. AMN Healthcare Services has a consensus price target of $39.17, suggesting a potential upside of 9.53%. Given AMN Healthcare Services' stronger consensus rating and higher probable upside, analysts clearly believe AMN Healthcare Services is more favorable than Medpace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medpace
0 Sell rating(s)
10 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.23
AMN Healthcare Services
1 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.33

Medpace has a net margin of 18.24% compared to AMN Healthcare Services' net margin of 3.10%. Medpace's return on equity of 99.76% beat AMN Healthcare Services' return on equity.

Company Net Margins Return on Equity Return on Assets
Medpace18.24% 99.76% 24.47%
AMN Healthcare Services 3.10%23.42%7.19%

78.0% of Medpace shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 20.5% of Medpace shares are owned by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Medpace beats AMN Healthcare Services on 10 of the 15 factors compared between the two stocks.

How does AMN Healthcare Services compare to Veeva Systems?

AMN Healthcare Services (NYSE:AMN) and Veeva Systems (NYSE:VEEV) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk, earnings and dividends.

Veeva Systems has a net margin of 29.34% compared to AMN Healthcare Services' net margin of 3.10%. AMN Healthcare Services' return on equity of 23.42% beat Veeva Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
AMN Healthcare Services3.10% 23.42% 7.19%
Veeva Systems 29.34%14.25%11.71%

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 88.2% of Veeva Systems shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by insiders. Comparatively, 10.6% of Veeva Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Veeva Systems has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Veeva Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AMN Healthcare Services$2.73B0.51-$95.70M$2.7513.00
Veeva Systems$3.20B13.47$908.91M$6.0843.71

In the previous week, Veeva Systems had 15 more articles in the media than AMN Healthcare Services. MarketBeat recorded 19 mentions for Veeva Systems and 4 mentions for AMN Healthcare Services. AMN Healthcare Services' average media sentiment score of 0.58 beat Veeva Systems' score of 0.54 indicating that AMN Healthcare Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AMN Healthcare Services
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Veeva Systems
7 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive

AMN Healthcare Services presently has a consensus target price of $39.17, indicating a potential upside of 9.53%. Veeva Systems has a consensus target price of $316.79, indicating a potential upside of 19.19%. Given Veeva Systems' stronger consensus rating and higher probable upside, analysts clearly believe Veeva Systems is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AMN Healthcare Services
1 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.33
Veeva Systems
1 Sell rating(s)
8 Hold rating(s)
19 Buy rating(s)
0 Strong Buy rating(s)
2.64

AMN Healthcare Services has a beta of 0.42, suggesting that its stock price is 58% less volatile than the broader market. Comparatively, Veeva Systems has a beta of 0.89, suggesting that its stock price is 11% less volatile than the broader market.

Summary

Veeva Systems beats AMN Healthcare Services on 13 of the 16 factors compared between the two stocks.

How does AMN Healthcare Services compare to West Pharmaceutical Services?

AMN Healthcare Services (NYSE:AMN) and West Pharmaceutical Services (NYSE:WST) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends, earnings and media sentiment.

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by company insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

West Pharmaceutical Services has a net margin of 18.81% compared to AMN Healthcare Services' net margin of 3.10%. AMN Healthcare Services' return on equity of 23.42% beat West Pharmaceutical Services' return on equity.

Company Net Margins Return on Equity Return on Assets
AMN Healthcare Services3.10% 23.42% 7.19%
West Pharmaceutical Services 18.81%21.78%15.99%

AMN Healthcare Services currently has a consensus price target of $39.17, indicating a potential upside of 9.53%. West Pharmaceutical Services has a consensus price target of $424.67, indicating a potential upside of 8.79%. Given AMN Healthcare Services' higher possible upside, analysts clearly believe AMN Healthcare Services is more favorable than West Pharmaceutical Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AMN Healthcare Services
1 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.33
West Pharmaceutical Services
0 Sell rating(s)
1 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.93

AMN Healthcare Services has a beta of 0.42, suggesting that its share price is 58% less volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.13, suggesting that its share price is 13% more volatile than the broader market.

In the previous week, West Pharmaceutical Services had 10 more articles in the media than AMN Healthcare Services. MarketBeat recorded 14 mentions for West Pharmaceutical Services and 4 mentions for AMN Healthcare Services. West Pharmaceutical Services' average media sentiment score of 0.97 beat AMN Healthcare Services' score of 0.58 indicating that West Pharmaceutical Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AMN Healthcare Services
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
West Pharmaceutical Services
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

West Pharmaceutical Services has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AMN Healthcare Services$2.73B0.51-$95.70M$2.7513.00
West Pharmaceutical Services$3.07B8.85$493.70M$8.9143.81

Summary

West Pharmaceutical Services beats AMN Healthcare Services on 12 of the 16 factors compared between the two stocks.

How does AMN Healthcare Services compare to LifeStance Health Group?

AMN Healthcare Services (NYSE:AMN) and LifeStance Health Group (NASDAQ:LFST) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, institutional ownership, valuation, dividends and profitability.

99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are held by institutional investors. 1.1% of AMN Healthcare Services shares are held by insiders. Comparatively, 3.5% of LifeStance Health Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, AMN Healthcare Services had 1 more articles in the media than LifeStance Health Group. MarketBeat recorded 4 mentions for AMN Healthcare Services and 3 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 0.67 beat AMN Healthcare Services' score of 0.58 indicating that LifeStance Health Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AMN Healthcare Services
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LifeStance Health Group
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

LifeStance Health Group has lower revenue, but higher earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AMN Healthcare Services$2.73B0.51-$95.70M$2.7513.00
LifeStance Health Group$1.42B3.69$9.66M$0.1972.68

AMN Healthcare Services presently has a consensus target price of $39.17, suggesting a potential upside of 9.53%. LifeStance Health Group has a consensus target price of $14.86, suggesting a potential upside of 7.58%. Given AMN Healthcare Services' higher possible upside, analysts clearly believe AMN Healthcare Services is more favorable than LifeStance Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AMN Healthcare Services
1 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.33
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.70

AMN Healthcare Services has a beta of 0.42, meaning that its stock price is 58% less volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.35, meaning that its stock price is 35% more volatile than the broader market.

LifeStance Health Group has a net margin of 4.29% compared to AMN Healthcare Services' net margin of 3.10%. AMN Healthcare Services' return on equity of 23.42% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
AMN Healthcare Services3.10% 23.42% 7.19%
LifeStance Health Group 4.29%4.82%3.30%

Summary

LifeStance Health Group beats AMN Healthcare Services on 10 of the 17 factors compared between the two stocks.

Get AMN Healthcare Services News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AMN vs. The Competition

MetricAMN Healthcare ServicesHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$1.53B$10.80B$7.78B$21.74B
Dividend YieldN/A2.54%2.47%3.83%
P/E Ratio13.0034.7433.1625.37
Price / Sales0.511.978.103.51
Price / Cash4.7822.8921.0115.54
Price / Book1.783.414.263.45
Net Income-$95.70M$329.93M$3.50B$1.07B
1 Month Performance-16.90%-7.35%-10.48%-7.17%
1 Year Performance117.57%10.81%-4.61%0.56%

AMN Healthcare Services Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AMN
AMN Healthcare Services
2.2789 of 5 stars
$35.76
+4.1%
$39.17
+9.5%
+133.4%$1.53B$2.73B13.002,664
EYE
National Vision
3.5193 of 5 stars
$18.40
-1.8%
$29.27
+59.1%
-32.0%$1.47B$2.06B22.9113,138
MEDP
Medpace
2.8563 of 5 stars
$644.12
-0.6%
$649.27
+0.8%
+4.0%$18.02B$2.84B35.716,200
VEEV
Veeva Systems
4.1369 of 5 stars
$297.22
-0.7%
$317.42
+6.8%
-1.9%$48.12B$3.20B48.887,928
WST
West Pharmaceutical Services
4.0332 of 5 stars
$417.72
0.0%
$424.67
+1.7%
+51.6%$29.12B$3.07B46.9210,800

Related Companies and Tools


This page (NYSE:AMN) was last updated on 11/21/2026 by MarketBeat.com Staff.
From Our Partners